title: Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line.
abstract: Pathological studies have determined that fibrillar forms of amyloid-beta protein (Abeta) comprise the characteristic neuritic plaques in Alzheimer's disease (AD). These studies have also revealed significant inflammatory markers such as activated microglia and cytokines surrounding the plaques. Although the plaques are a hallmark of AD, they are only part of an array of Abeta aggregate morphologies observed in vivo. Interestingly, not all of these Abeta deposits provoke an inflammatory response. Since structural polymorphism is a prominent feature of Abeta aggregation both in vitro and in vivo, we sought to clarify which Abeta morphology or aggregation species induces the strongest proinflammatory response using human THP-1 monocytes as a model system. An aliquot of freshly reconstituted Abeta(1-42) in sterile water (100 microM, pH 3.6) did not effectively stimulate the cells at a final Abeta concentration of 15 microM. However, quiescent incubation of the peptide at 4 degrees C for 48-96 h greatly enhanced its ability to induce tumor necrosis factor-alpha (TNFalpha) production, the level of which surprisingly declined upon further aggregation. Imaging of the Abeta(1-42) aggregation solutions with atomic force microscopy indicated that the best cellular response coincided with the appearance of fibrillar structures, yet conditions that accelerated or increased the level of Abeta(1-42) fibril formation such as peptide concentration, temperature, or reconstitution in NaOH/PBS at pH 7.4 diminished its ability to stimulate the cells. Finally, depletion of the Abeta(1-42) solution with an antibody that recognizes fibrillar oligomers dramatically weakened the ability to induce TNFalpha production, and size-exclusion separation of the Abeta(1-42) solution provided further characterization of an aggregated species with proinflammatory activity. The findings suggested that an intermediate stage Abeta(1-42) fibrillar precursor is optimal for inducing a proinflammatory response in THP-1 monocytes.
authors.affiliation: Department of Chemistry and Biochemistry and Center for Nanoscience, University of Missouri, St. Louis, Missouri 63121, USA.
authors.forename: Deepa
authors.initials: D
authors.lastname: Ajit
authors.forename: Maria L D
authors.initials: ML
authors.lastname: Udan
authors.forename: Geeta
authors.initials: G
authors.lastname: Paranjape
authors.forename: Michael R
authors.initials: MR
authors.lastname: Nichols
mesh_terms: D000544:Alzheimer Disease / Q000209:etiology / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D002460:Cell Line; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D018625:Microscopy, Atomic Force; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism*; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D011498:Protein Precursors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D020836:Protein Structure, Quaternary; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
chemical_list: D016229:Amyloid beta-Peptides; D018836:Inflammation Mediators; D010446:Peptide Fragments; D011498:Protein Precursors; D014409:Tumor Necrosis Factor-alpha; C078592:amyloid beta-protein (1-40); C075222:amyloid beta-protein (1-42)
references.citation: J Biol Chem. 2005 Jan 28;280(4):2471-80
references.pmid: 15528204
references.citation: FASEB J. 2004 Jan;18(1):203-5
references.pmid: 14597556
references.citation: J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1200-5
references.pmid: 12933918
references.citation: Mol Neurodegener. 2007 Sep 26;2:18
references.pmid: 17897471
references.citation: Neurobiol Aging. 2009 Nov;30(11):1792-804
references.pmid: 18339452
references.citation: Nat Med. 2001 Mar;7(3):369-72
references.pmid: 11231639
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):4012-7
references.pmid: 19228947
references.citation: Nat Rev Neurosci. 2007 Jul;8(7):499-509
references.pmid: 17551515
references.citation: J Biol Chem. 2002 Aug 30;277(35):32046-53
references.pmid: 12058030
references.citation: Biochemistry. 2003 Mar 25;42(11):3151-9
references.pmid: 12641446
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Neurosci Lett. 1987 Aug 18;79(1-2):195-200
references.pmid: 3670729
references.citation: Nature. 2008 Feb 7;451(7179):720-4
references.pmid: 18256671
references.citation: J Neurosci. 2001 Feb 15;21(4):1179-88
references.pmid: 11160388
references.citation: Nature. 1996 Aug 22;382(6593):716-9
references.pmid: 8751442
references.citation: J Biol Chem. 2003 Mar 28;278(13):11612-22
references.pmid: 12499373
references.citation: J Biol Chem. 1999 Sep 3;274(36):25945-52
references.pmid: 10464339
references.citation: J Neurochem. 2000 Mar;74(3):1017-25
references.pmid: 10693932
references.citation: Nature. 2002 Apr 4;416(6880):535-9
references.pmid: 11932745
references.citation: Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
references.pmid: 17245412
references.citation: Biochemistry. 1999 Jul 13;38(28):8972-80
references.pmid: 10413470
references.citation: Chem Biol. 1997 Feb;4(2):119-25
references.pmid: 9190286
references.citation: Nature. 1995 Apr 13;374(6523):647-50
references.pmid: 7715705
references.citation: J Neuroimmunol. 1996 Jun;67(1):21-9
references.pmid: 8707927
references.citation: Brain Res. 1997 Jan 30;747(1):114-21
references.pmid: 9042534
references.citation: Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12243-7
references.pmid: 7991613
references.citation: Am J Pathol. 1964 Feb;44:269-97
references.pmid: 14119171
references.citation: J Neurosci. 2006 May 31;26(22):6011-8
references.pmid: 16738244
references.citation: Cancer Res. 1988 Sep 1;48(17):4827-33
references.pmid: 3409223
references.citation: J Mol Biol. 2004 Jan 2;335(1):247-60
references.pmid: 14659754
references.citation: Nature. 1996 Aug 22;382(6593):685-91
references.pmid: 8751438
references.citation: Science. 2003 Apr 18;300(5618):486-9
references.pmid: 12702875
references.citation: J Biol Chem. 2006 Feb 17;281(7):4292-9
references.pmid: 16361260
references.citation: Neurobiol Aging. 2001 Nov-Dec;22(6):837-42
references.pmid: 11754990
references.citation: J Neurosci. 2003 Apr 1;23(7):2665-74
references.pmid: 12684452
references.citation: Cell Physiol Biochem. 2007;20(6):947-56
references.pmid: 17982277
references.citation: Biochemistry. 2002 May 14;41(19):6115-27
references.pmid: 11994007
references.citation: J Biol Chem. 1997 Aug 29;272(35):22364-72
references.pmid: 9268388
references.citation: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1485-90
references.pmid: 11818542
references.citation: Cell. 1993 Jun 18;73(6):1055-8
references.pmid: 8513491
references.citation: Biochemistry. 2000 Nov 14;39(45):13748-59
references.pmid: 11076514
references.citation: Trends Cell Biol. 1998 Nov;8(11):447-53
references.pmid: 9854312
references.citation: Nat Cell Biol. 2004 Nov;6(11):1054-61
references.pmid: 15516999
references.citation: Nat Struct Biol. 1995 Nov;2(11):990-8
references.pmid: 7583673
references.citation: Nat Med. 2002 Sep;8(9):936-8
references.pmid: 12205453
references.citation: Methods Mol Biol. 2005;299:19-33
references.pmid: 15980593
references.citation: J Neurochem. 2008 Jan;104(2):524-33
references.pmid: 17986235
references.citation: Science. 2005 Jan 14;307(5707):262-5
references.pmid: 15653506
references.citation: Brain Res. 1991 Nov 1;563(1-2):311-4
references.pmid: 1786545
references.citation: Exp Gerontol. 1998 Aug;33(5):371-8
references.pmid: 9762518
references.citation: Glia. 1993 Jan;7(1):75-83
references.pmid: 8423065